By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
News for IndiaNews for IndiaNews for India
  • Home
  • Posts
  • Search Page
  • About us
Reading: Stocks to buy for short term: From Oil India to Aurobindo Pharma— Jigar Patel of Anand Rathi recommends 3 shares | Stock Market News
Share
Font ResizerAa
News for IndiaNews for India
Font ResizerAa
  • Economics
  • Business
  • Home
  • Categories
    • Business
    • Economics
  • About us
  • Sitemap
Follow US
  • Advertise
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
News for India > Business > Stocks to buy for short term: From Oil India to Aurobindo Pharma— Jigar Patel of Anand Rathi recommends 3 shares | Stock Market News
Business

Stocks to buy for short term: From Oil India to Aurobindo Pharma— Jigar Patel of Anand Rathi recommends 3 shares | Stock Market News

Last updated: November 3, 2025 9:00 am
7 months ago
Share
SHARE


Contents
Stock picks for the short termOil India | Previous close: ₹433.35 | Buying range: ₹425 to ₹435 | Target price: ₹490 | Stop loss: ₹400Aurobindo Pharma | Previous close: ₹1,138.90 | Buying range: ₹1,120 to ₹1,140 | Target price: ₹1,245 | Stop loss: ₹1,070Latent View Analytics | Previous close: ₹448.35 | Buying range: ₹440 to ₹450 | Target price: ₹490 | Stop loss: ₹420

Stocks to buy for short term: The Indian stock market concluded last week on a sombre note, staying in a range of 26,100–25,700, reflecting indecision among market participants after recent volatility.

Market benchmark Nifty 50 slipped by 0.30 per cent for the week ended October 31, snapping its four-week winning streak.

Experts highlight that, on the technical front, the Nifty 50 has formed a double top formation on the daily chart, near 26,100, indicating potential exhaustion of the short-term uptrend. The hourly MACD has also exhibited a negative divergence, indicating weakening momentum and a potential short-term pullback.

According to Jigar S. Patel, Senior Manager of Equity Technical Research at Anand Rathi Share and Stock Brokers, a decisive close below 25,700 may invite further profit booking, potentially dragging the index toward 25,500, which serves as the next key support level. On the other hand, if the index manages to sustain above 25,800, it could trigger a recovery toward 26,100 once again, thereby keeping the range-bound structure intact.

Also Read | Nifty 50, Sensex on November 3: What to expect in trade today

“Going forward, 25,700 will act as an immediate support, while 25,500 holds significance as a major support level, aligning with the previous weekly swing high — a zone where buyers are likely to re-enter the market. On the higher side, 26,100 remains a strong resistance, and a breakout above this level would be required to resume bullish momentum,” said Patel.

“Traders should remain cautious near resistance zones and look for buying opportunities only near the mentioned support areas unless the index decisively breaks above 26,100,” Patel said.

Also Read | Buy or sell: Vaishali Parekh recommends three stocks to buy today — 3 Nov 2025

Stock picks for the short term

Jigar Patel recommends buying shares of Oil India, Aurobindo Pharma, and Latent View Analytics for the next one to two weeks.

Oil India | Previous close: ₹433.35 | Buying range: ₹425 to ₹435 | Target price: ₹490 | Stop loss: ₹400

Patel underscored that Oil India has recently witnessed a decisive breakout after consolidating in the range of ₹405– ₹428. The breakout occurred above the Ichimoku Cloud, aligning with both the 200-day EMA and 200-day SMA — indicating strong underlying trend confirmation.

The MACD has also given a bullish crossover above the zero line, suggesting the start of fresh upward momentum.

The breakout was accompanied by a sharp rise in trading volumes, reinforcing the move’s authenticity.

“Given these bullish technical signals, traders are advised to initiate long positions in the ₹425– ₹435 zone, with a potential target of ₹490 and a stop-loss at ₹400 on a daily closing basis,” said Patel.

Oil India technical chart

Aurobindo Pharma | Previous close: ₹1,138.90 | Buying range: ₹1,120 to ₹1,140 | Target price: ₹1,245 | Stop loss: ₹1,070

Patel pointed out that Aurobindo Pharma has registered a strong breakout after consolidating in the range of approximately ₹1,075– ₹1,130.

The stock has moved above the Ichimoku Cloud and the 50-day EMA, signalling a firm shift in momentum and confirmation of a bullish trend.

The MACD indicator has displayed a positive crossover above the zero line, pointing toward renewed buying interest. The breakout was supported by a noticeable surge in trading volumes, validating the strength of the move.

“Considering these robust technical signals, traders may look to enter long positions in the ₹1,120– ₹1,140 zone, aiming for a target of ₹1,245, while maintaining a stop-loss at ₹1,070 on a daily closing basis,” said Patel.

Aurobindo Pharma technical chart

Latent View Analytics | Previous close: ₹448.35 | Buying range: ₹440 to ₹450 | Target price: ₹490 | Stop loss: ₹420

According to Patel, Latent View Analytics has given a dual trendline breakout after a prolonged consolidation phase around its 200-day EMA, indicating a shift toward bullish momentum.

The stock has also broken out above the Ichimoku Cloud, further strengthening the positive outlook.

A notable surge in trading volumes during the breakout confirms genuine buying interest, while the MACD’s bullish crossover above the zero line adds to the conviction of a trend reversal.

“Based on these strong technical confirmations, traders are advised to initiate long positions in the ₹440– ₹450 zone, with an upside target of ₹490 and a stop-loss at ₹420 on a daily closing basis,” said Patel.

Latent View Analytics technical chart

Read all market-related news here

Read more stories by Nishant Kumar

Disclaimer: This story is for educational purposes only. The views and recommendations expressed are those of the expert, not Mint. We advise investors to consult with certified experts before making any investment decisions, as market conditions can change rapidly and circumstances may vary.



Source link

You Might Also Like

Access Denied

Access Denied

Can Nifty 50 hit 42,000 by 2028-end despite geopolitical uncertainty? CNI InfoXchange explains how | Stock Market News

Access Denied

Access Denied

TAGGED:Aurobindo Pharma share priceLatent View Analytics share priceoil india share priceShares to buy for short termstock picks for short termStocks to buy for short term
Share This Article
Facebook Twitter Email Print
Previous Article Lenskart IPO Day 2: Issue booked 1.13x so far. Check GMP, review, subscription status. Should you subscribe? | Stock Market News
Next Article Gold price today: Rates rise amid softer dollar, healthy spot demand; experts highlight key levels for MCX gold, silver | Stock Market News

We influence 20 million users and is the number one business and technology news network on the planet.

Find Us on Socials

News for IndiaNews for India
© Wealth Wave Designed by Preet Patel. All Rights Reserved.
  • BUSINESS